Amy Jensen was hoping for another baby when persistent changes in her breast led her to seek further testing. On the morning of a planned biopsy, she learned she was pregnant. She later pursued the biopsy at around thirteen weeks of pregnancy and was diagnosed with HER2-positive invasive ductal carcinoma.
Amy and her husband, Chad, shared the news with their daughters. Alongside concerns about treatment, Amy worried about how losing her hair might affect her children.
At eighteen weeks pregnant, Amy underwent surgery with Dr. Teresa Reading at IMC Hospital, including a mastectomy and reconstruction. Her subsequent care at Utah Cancer Specialists included chemotherapy and Herceptin.
Chad researched scalp cooling and connected with Dr. Gregory Litton. Amy used the DigniCap system during treatment. Although initially anxious about discomfort, she found it more tolerable than expected, and Dr. Litton observed that she was retaining her hair.
The July 2019 account reported that Amy was cancer-free. Her family had also welcomed Jacob, born in December 2018.
Adapted from the original Utah Cancer Specialists article. Photo from Utah Cancer Specialists.
This account reflects the original publication date. Each patient’s experience is different; individual results do not predict another person’s outcome.